Badawy, A. (2020). Immunotherapy of COVID-19 with poly (ADP-ribose) polymerase inhibitors: Starting with nicotinamide. Biosci Rep.
Chicago-stil citatBadawy, Abdulla A.-B. "Immunotherapy of COVID-19 With Poly (ADP-ribose) Polymerase Inhibitors: Starting With Nicotinamide." Biosci Rep 2020.
MLA-referensBadawy, Abdulla A.-B. "Immunotherapy of COVID-19 With Poly (ADP-ribose) Polymerase Inhibitors: Starting With Nicotinamide." Biosci Rep 2020.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.